| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/05/2009 | US20090062329 Bisnaphthalimidopropyl derivative compounds with anti-parasite and anti-cancer activity |
| 03/05/2009 | US20090062328 Oxime and Hydroxylamine Substituted Imidazo[4,5-c] Ring Compounds and Methods |
| 03/05/2009 | US20090062327 Inhibitors of AKT Activity |
| 03/05/2009 | US20090062326 M3 muscarinic receptor antagonists for treatment of m3 muscarinic receptor-expressing tumors |
| 03/05/2009 | US20090062325 Deuterium-enriched tiotropium |
| 03/05/2009 | US20090062324 Catecholamine derivatives and prodrugs thereof |
| 03/05/2009 | US20090062323 Deuterium-enriched irinotecan |
| 03/05/2009 | US20090062322 Novel Tricyclic Spiropiperidines or Spiropyrrolidines |
| 03/05/2009 | US20090062321 Hydroxybenzoate Salts Of Metanicotine Compounds |
| 03/05/2009 | US20090062320 Method of Treating Disorders Mediated by the Fibroblast Growth Factor Receptor |
| 03/05/2009 | US20090062319 Methods of inhibiting the interaction between s100 and the receptor for advanced glycation end-products |
| 03/05/2009 | US20090062318 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof |
| 03/05/2009 | US20090062317 Medicinal use of receptor ligands |
| 03/05/2009 | US20090062316 Deuterium-enriched pelitrexol |
| 03/05/2009 | US20090062315 Pharmaceutical Acceptable Composition Containing Non-Steroidal Anti-Inflammatory Drug and Local Anesthetics |
| 03/05/2009 | US20090062314 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof |
| 03/05/2009 | US20090062313 Pde5 inhibitor compositions and methods for treating cardiac indications |
| 03/05/2009 | US20090062312 Deuterium-enriched indiplon |
| 03/05/2009 | US20090062311 Macrocylic inhibitors of hepatitis c virus |
| 03/05/2009 | US20090062310 Deuterium-enriched voriconazole |
| 03/05/2009 | US20090062309 Therapeutic compositions for the treatment of cardiovascular diseases and methods for use therefor |
| 03/05/2009 | US20090062308 Methods of using sodium channel blockers |
| 03/05/2009 | US20090062307 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents |
| 03/05/2009 | US20090062306 Novel pyrimidine compounds having benzyl (heterocyclic methyl) amine structure and medicament comprising the same |
| 03/05/2009 | US20090062305 Deuterium-enriched cetirizine |
| 03/05/2009 | US20090062304 Benzimidazole derivatives and their use for modulating the gaba-alpha receptor complex |
| 03/05/2009 | US20090062303 Deuterium-enriched ziprasidone |
| 03/05/2009 | US20090062302 Jak2 Tyrosine Kinase Inhibition |
| 03/05/2009 | US20090062301 Pharmaceutical combination composition comprising at least one pkc inhibitor and at least one ja k3 kinase inhibitor for treating autoimmune disorders |
| 03/05/2009 | US20090062300 Deuterium-enriched prazosin |
| 03/05/2009 | US20090062299 Deuterium-enriched doxazosin |
| 03/05/2009 | US20090062298 Deuterium-enriched sildenafil |
| 03/05/2009 | US20090062297 Hydroxyalkylarylamide Derivatives |
| 03/05/2009 | US20090062296 Nitrooxyderivatives of prostaglandin amides, e.g., N-(3-(nitrooxy)propyl) 1R-[1 alpha (Z),2 beta (R*),3 alpha ,5 alpha ]]-7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-5-heptenamide; reduced side effects,wider pharmacological activity, enhanced tolerability, long-acting hypotensive activity |
| 03/05/2009 | US20090062295 Pharmaceutical Products |
| 03/05/2009 | US20090062294 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 03/05/2009 | US20090062293 1,4-Substituted Piperazine Derivatives |
| 03/05/2009 | US20090062292 4-((R)-5-cyclopentyl-4-ethyl-4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridin-7-ylamino)-3-methoxy-N-methylbenzamide, useful for treating or preventing autoimmune, inflammatory, proliferative, or hyperproliferative disease, a neurodegenerative disease, or an immunologically-mediated disease |
| 03/05/2009 | US20090062291 Phosphodiesterase 10 inhibitors |
| 03/05/2009 | US20090062290 Heterocycles as potassium channel modulators |
| 03/05/2009 | US20090062289 Immunomodulating oxopyrrazolocinnolines as cd 80 inhibitors |
| 03/05/2009 | US20090062288 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith |
| 03/05/2009 | US20090062287 thromboembolic and/or inflammatory disorders; 4-Aminomethyl-cyclohexanecarboxylic acid (1-biphenyl-3-yl-2-phenyl-ethyl)-amide; selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; improved pharmacological properties, plasma kallikrein activity |
| 03/05/2009 | US20090062286 Crystal Structure of SMYD3 Protein |
| 03/05/2009 | US20090062285 Sulfur-containing compound, method of preparation and pharmaceutical uses thereof |
| 03/05/2009 | US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives |
| 03/05/2009 | US20090062283 Deuterium-enriched linezolid |
| 03/05/2009 | US20090062282 Substituted Amino-Pyrimidones and Uses Thereof |
| 03/05/2009 | US20090062281 such as 7-(2-[1,4']Bipiperidinyl-1'-yl-ethoxy)-6-methoxy-4-(4-phenoxy-phenylamino)-quinoline-3-carbonitrile, useful in the prevention of diseases associated with the Ras/Raf/MEK signaling cascade in a mammals, such as tumors, cancer, strokes, osteoporosis, arthritis and inflammatory diseases |
| 03/05/2009 | US20090062280 Ophthalmic Compositions for Treating Ocular Hypertension |
| 03/05/2009 | US20090062279 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
| 03/05/2009 | US20090062278 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 03/05/2009 | US20090062277 Phosphodiesterase 10 inhibitors |
| 03/05/2009 | US20090062276 Pyridopyrimidine protein tyrosine phosphatase inhibitors |
| 03/05/2009 | US20090062275 stem cell factor receptor antagonists such as 3-{4-[(4-(trifluoromethoxy)benzyl)oxy]phenyl}-N-(2-morpholin-4-ylethyl)-3H-imidazo[4,5-b]pyridine-6-carboxamide, used for the treatment of cancer and tumors; anticarcinogenic and antitumor agents |
| 03/05/2009 | US20090062274 Pyridopyrimidinone inhibitors of pi3kalpha |
| 03/05/2009 | US20090062273 3-H-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same. |
| 03/05/2009 | US20090062272 Imidazoquinolinyl sulfonamides |
| 03/05/2009 | US20090062271 Antithrombotic Diamides |
| 03/05/2009 | US20090062270 Spiro 2,4 pyrimidinediamine compounds and their uses |
| 03/05/2009 | US20090062269 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 03/05/2009 | US20090062268 Novel inhibitors of poly(adp-ribose)polymerase (parp) |
| 03/05/2009 | US20090062267 L-ALANINE DERIVATIVES AS a5beta1 ANTAGONISTS |
| 03/05/2009 | US20090062266 7-methoxy-2-methyl-N-[[(5S)-[3-[3-fluoro-4-(piperazin-1-yl)phenyl]-2-oxo-5-oxazolidinylmethyl]-3-quinolinecarboxamide, useful for the treatment of grampositive and some gramnegative bacterial infections, with a weak monoamine oxidase inhibitory activity |
| 03/05/2009 | US20090062265 6-({4-[(2,3-Dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]-1-piperidinyl}methyl)-7-fluoro-5,6-dihydro-3H-pyrrolo[1,2,3-de]quinoxalin-3-one; may be formulated for administration in any convenient way for use in human or veterinary medicine |
| 03/05/2009 | US20090062264 Salts of potassium atp channel openers and uses thereof |
| 03/05/2009 | US20090062263 4-Hydroxy-5,6-dihydro-1H-pyridin-2-one compounds |
| 03/05/2009 | US20090062262 Non steroidal glucocorticoid receptor modulators |
| 03/05/2009 | US20090062261 Nitrogen-containing heterocycle derivatives substituted with cyclic group |
| 03/05/2009 | US20090062260 Compounds and compositions as lxr modulators |
| 03/05/2009 | US20090062259 Bezothiazol Derivatives as Beta2 Adrenoreceptor Agonists |
| 03/05/2009 | US20090062258 Fused pyrimidine derivative and use thereof |
| 03/05/2009 | US20090062257 Deuterium-enriched varenicline |
| 03/05/2009 | US20090062256 LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION |
| 03/05/2009 | US20090062255 Tumor-targeting evaluation methodology and compounds related thereto |
| 03/05/2009 | US20090062254 Acute Treatment of Headache with Phenothiazine Antipsychotics |
| 03/05/2009 | US20090062253 Heterocyclodiazepine cannabinoid receptor modulators for treatment of disease |
| 03/05/2009 | US20090062252 Therapeutic isoxazole compounds |
| 03/05/2009 | US20090062251 Novel Compounds 002 |
| 03/05/2009 | US20090062250 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability |
| 03/05/2009 | US20090062249 An intraocular, biodegradable drug delivery system comprising anecortave acetate and a biodegradable glycolic acid-lactic acid copolymer effective in releasing the immunosuppressant into the eye over a period of > 3 weeks; sustained release from a single pellet or a single extruded filament |
| 03/05/2009 | US20090062248 Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists |
| 03/05/2009 | US20090062247 METHODS FOR INHIBITING TGF-beta |
| 03/05/2009 | US20090062246 Therapeutic treatment-014 |
| 03/05/2009 | US20090062245 Modulation of Neurodegenerative Diseases Through The Progesterone Receptor |
| 03/05/2009 | US20090062244 Pharmaceutical composition |
| 03/05/2009 | US20090062243 Lupane-Type Triterpenoids Modified at 30-Position and Analogues Thereof |
| 03/05/2009 | US20090062242 Methods and compositions for treating gastrointestinal conditions |
| 03/05/2009 | US20090062241 Highly porous, fast-disintegrating solid dosage form and its way of manufacturing comprising the preparation of a powder and a freezedrying step |
| 03/05/2009 | US20090062240 Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate |
| 03/05/2009 | US20090062239 Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery |
| 03/05/2009 | US20090062238 Method for treatment of neuropathic pain |
| 03/05/2009 | US20090062237 Evaluating immune competence |
| 03/05/2009 | US20090062236 Programmable genotoxic agents and uses therefor |
| 03/05/2009 | US20090062235 Inhibitors of Dipeptidylpeptidase IV |
| 03/05/2009 | US20090062234 Substituted organopolysiloxanes and use thereof |
| 03/05/2009 | US20090062233 Modified starch material of biocompatible hemostasis |
| 03/05/2009 | US20090062232 High-Purity Xylooligosaccharide Compositions |
| 03/05/2009 | US20090062231 Appetite Suppressant Composition and Method of Appetite Suppression |
| 03/05/2009 | US20090062230 Novel cationic 17 alpha-substituted-estradiol derivatives useful as anti-cancer agent |